Cargando…
Management of Diabetes and Hypertension within the Gulf Region: Updates on Treatment Practices and Therapies
Cardiovascular disease (CVD) is a leading cause of death globally, driven by the high rates of risk factors, such as diabetes and hypertension. As the prevalence of these risk factors is particularly high in the Gulf region, better diagnosis and management of type 2 diabetes (T2D) and hypertension h...
Autores principales: | Hassanein, Mohamed, Akbar, Mousa A. J., Al-shamiri, Mostafa, Amir, Ashraf, Amod, Aslam, Chudleigh, Richard, Elhadd, Tarik, Heshmat, Hussien, Jibani, Mahdi, Al Saleh, Yousef M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178531/ https://www.ncbi.nlm.nih.gov/pubmed/35679010 http://dx.doi.org/10.1007/s13300-022-01282-4 |
Ejemplares similares
-
Safety and Effectiveness of Insulin Glargine 300 U/mL in Participants with Type 2 Diabetes Who Fast During Ramadan in The Gulf Region: A Subgroup Analysis of the Real-World ORION Study
por: Malik, Rayaz A., et al.
Publicado: (2022) -
Comparative Assessment of Preoperative versus Postoperative Dexamethasone on Postoperative Complications following Lower Third Molar Surgical Extraction
por: Al-Shamiri, Hashem M., et al.
Publicado: (2017) -
Sulfonylureas in the Current Practice of Type 2 Diabetes Management: Are They All the Same? Consensus from the Gulf Cooperation Council (GCC) Countries Advisory Board on Sulfonylureas
por: Al-Saleh, Yousef, et al.
Publicado: (2021) -
Correction to: Sulfonylureas in the Current Practice of Type 2 Diabetes Management: Are They All the Same? Consensus from the Gulf Cooperation Council (GCC) Countries Advisory Board on Sulfonylureas
por: Al-Saleh, Yousef, et al.
Publicado: (2021) -
Roadmap for the Management of Type 2 Diabetes and Hypertension in the Middle East: Review of the 2022 EVIDENT Summit
por: Al Saleh, Yousef, et al.
Publicado: (2023)